A federal appeals court on Monday vacated a district court's earlier dismissal of plaintiff claims that they were not warned that prenatal ingestion of Kenvue's (KVUE) Tylenol and its generic equivalents could cause autism spectrum disorder and attention-deficit/hyperactivity disorder.
The two cases impacted by the appeals court ruling were remanded for further proceedings.
Kenvue didn't immediately reply to a request for comment from.
Price: $19.30, Change: $-0.18, Percent Change: -0.95%